Background: This study aims to investigate the effects of Salvia officinalis on the severity of the premenstrual syndrome (PMS). Methods: This was a triple-blinded randomized clinical trial on 90 college students in Tehran, Iran. The participants were randomly divided into 2 groups who were treated with 500-mg Salvia officinalis capsules or placebo once a day for 2 consecutive months. Data were collected using a questionnaire and a daily form for recording symptoms of PMS. Results: The mean decreases in severity of the symptoms in the Salvia officinalis extract-treated group during the first and second months after treatment were 19.84% and 23.42%, respectively. The comparison of the PMS physical and psychological symptoms demonstrated a decrease following treatment in both groups, with more remarkable reduction in the Salvia officinalis group (p < 0.001). Conclusion: Salvia officinalis is an effective alternative agent to reduce the severity of psychological and physical symptoms of PMS.

Keywords:
Premenstrual syndrome, Salvia officinalis extract, Placebo, Clinical trial
1.
Chocano-Bedoya PO: Micronutrient Intake and Premenstrual Syndrome. Ph.D. Thesis, Amherst, University of Massachusetts, 2011, pp 3-302.
2.
Fritz MA, Speroff L: Clinical Gynecologic Endocrinology and Infertility, ed 8. Philadelphia, Lippincott Williams & Wilkins, 2011, pp 78-568.
3.
Direkvand Moghadam A, Kaikhavani S, Sayehmiri K: The worldwide prevalence of premenstrual syndrome: a systematic review and meta-analysis study. Iran J Obstet Gynecol Infertil 2013;16:8-17.
4.
Ramezani Tehrani F, Hashemi S, Robab Allameh M: Prevalence of premenstrual syndrome and some of its relative factors in reproductive age. Shahid Beheshti University of Medical Sciences, Tehran, Iran. Q Ofoghe Danesh 2012;18:121-127.
5.
Montazeri S: The comparison between effects of vitamins B6 and E on PMS students of Shahid Beheshti University of Medical Sciences in 1999 (in Persian). Ph.D. Thesis, Tehran, Shahid Beheshti University of Medical Sciences, 1999.
6.
Sammon CJ, Nazareth I, Petersen I: Recording and treatment of premenstrual syndrome in UK general practice: a retrospective cohort study. BMJ Open 2016;6:e010244.
7.
Chen HY, Huang BS, Lin YH, SU IH, Yang SH, Chen JL, Huang JW, Chen YC: Identifying Chinese herbal medicine for premenstrual syndrome: implications from a nationwide database. BMC Complement Altern Med 2014;14:206-215.
8.
Danno K, Colas A, Terzan, L, Bordet MF: Homeopathic treatment of premenstrual syndrome: a case series. Homeopathy 2013;102:59-65.
9.
Wakil L, Meltzer-Brody S, Girdler S: Premenstrual dysphoric disorder: How to alleviate her suffering. Curr Psychiatry 2012;11:22-32.
10.
Seedhom AE, Mohammed ES, Mahfouz EM: Life style factors associated with premenstrual syndrome among El-Minia University students, Egypt. ISRN Public Health 2013;2013:1-6.
11.
Milewicz A, Jedrzejuk D: Premenstrual syndrome: from etiology to treatment. Maturitas 2006;55:S47-S54.
12.
Sohrabi N, Kashanian M, Ghafoori SS, Malakouti SK: Evaluation of the effect of omega 3-fatty acids in the treatment of premenstrual syndrome: ‘a pilot trial'. Complement Ther Med 2013;21:141-146.
13.
Vichnin M, Freeman EW, Lin H, Hillman J, Bui S: Premenstrual syndrome (PMS) in adolescents: severity and impairment. J Pediatr Adolesc Gynecol 2006;19:397-402.
14.
Kapur N: Premenstrual symptoms and social disability. IJIKC 2016;2:8-13.
15.
Shabiri F, Jenabi E: Evaluation the effect of vitamin E on severity of muscle pain in students with premenstrual syndrome. Iran J Obstet Gynecol Infertil 2014;17:1-5.
16.
Pearlstein T: Treatment of premenstrual dysphoric disorder: therapeutic challenges. Expert Rev Clin Pharmacol 2016;9:493-496.
17.
Bertone-Johnson ER, Whitcomb BW, Rich-Edwards JW, Hankinson SE, Manson JE: Premenstrual syndrome and subsequent risk of hypertension in a prospective study. Am J Epidemiol 2015;182:1000-1009.
18.
Taavoni S, Barkhordari F, Goushegir A, Haghani H: Effect of royal jelly on premenstrual syndrome among Iranian medical sciences students: a randomized, triple-blind, placebo controlled study. Complement Ther Med 2014;22:601-606.
19.
Sabet-Birjandi S, Tadayon-Najafabadi M, Siyahpooshan A, Haghighizadeh M: Comparison of the effect of Hypericum perforatum and vitamin B6 in the treatment of premenstrual syndrome. J Zahedan Res Med Sci 2011;13:1-5.
20.
Hamidpour M, Hamidpour R, Hamidpour S, Shahlari M: Chemistry, pharmacology, and medicinal property of sage (Salvia officinalis) to prevent and cure illnesses such as obesity, diabetes, depression, dementia, lupus, autism, heart disease, and cancer. Afr J Tradit Complement Altern Med 2014;4:82-88.
21.
Abu-Darwish MS, Cabral C, Ferreira IV, Gonçalves MJ, Cavaleiro C, Cruz MT, Al-Bdour TH, Salgueiro L: Essential oil of common sage (Salviaofficinalis L.) from Jordan: assessment of safety in mammalian cells and its antifungal and anti-inflammatory potential. Bio Med Res Int 2013;2013:538940.
22.
Martins N, Barros L, Santos-Buelga C, Henriques M, Silva S, Ferreira IC: Evaluation of bioactive properties and phenolic compounds in different extracts prepared from Salvia officinalis L. Food Chem 2015;170:378-385.
23.
Patisaul HB: Phytoestrogen action in the adult and developing brain. J Neuroendocrinol 2005;17:57-64.
24.
Lephart ED, Setchell KD, Lund TD: Phytoestrogens: hormonal action and brain plasticity. Brain Res Bull 2005;65:193-198.
25.
Riaz M, Zia-Ul-Haq M, Saad B: Diet and herbal-derived medicines; in Riaz M, Zia-Ul-Haq M, Saad B: Anthocyanins and Human Health: Biomolecular and Therapeutic Aspects. Basel, Springer International Publishing, 2016, pp 1-19.
26.
Bulku E, Zinkovsky D, Patel P, Javia V, Lahoti T, Khodos I, Stohs SJ, Ray SD: A novel dietary supplement containing multiple phytochemicals and vitamins elevates hepatorenal and cardiac antioxidant enzymes in the absence of significant serum chemistry and genomic changes. Oxid Med Cell Longev 2010;3:129-144.
27.
Bauer J, Kuehnl S, Rollinger JM, Scherer O, Northoff H, Stuppner H, Werz O, Koeberle A: Carnosol and carnosic acids from Salvia officinalis inhibit microsomal prostaglandin E2 synthase-1. J Pharmacol Exp Ther 2012;342:169-176.
28.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, ed 4. Washington, DC, American Psychiatric Association, 1994.
29.
Suija K, Rajala U, Jokelainen J, Liukkonen T, Härkönen P, Keinänen-Kiukaanniemi S, Timonen M: Validation of the Whooley questions and the Beck Depression Inventory in older adults. J Scand J Primary Health Care 2012;30:259-264.
30.
Özcan M, Özkan G: Determination of antioxidant activity and total phenol contents of two Salvia extracts. Indian J Tradit Knowl 2015;14:226-230.
31.
Kheirkhah M, Abassinia K, Jahdi F, Agha Hosseini F, Hassani M: The effect of perforan on the mood symptoms of premenstrual syndrome. J Urmia Nurse Midwifery Faculty 2013;11:245-251.
32.
Ozgoli G, Esmaeili S, Nasiri N: The effect of oral orange peel on the severity of symptoms of premenstrual syndrome, double-blind, placebo-controlled clinical trial. J Reprod Fertil 2011;12:123-129.
33.
Sharifi F, Simbar M, Mojab F, Majd HA: Comparison of the effects of Matricaria chamomile (chamomile) extract and mefenamic acid on the intensity of premenstrual syndrome. Complement Ther Clin Pract 2014;20:81-88.
34.
Mousavi P, Zaheri H, Najar S, Afshari P: The effect of Vitagnus on physical and emotional symptoms of premenstrual syndrome: a randomized clinical trial. J Clin Nurs Midwifery 2015;4:68-76.
35.
Kalvandi R, Alimohammadi S, Pashmakian Z, Rajabi M: The effects of medicinal plants of Melissa officinalis and Salvia officinalis on primary dysmenorrhea. Sci J Hamadan Univ Med Sci 2014;21:105-111.
36.
Bajaj JK, Singh SJ, Khosla PP, Walia RA: Clinical efficacy of pyridoxine and mefenamic acid alone and in combination in premenstrual syndrome. Int J Med Clin Res 2012;3:115-117.
37.
Drife JO, Magowan B: Clinical Obstetrics and Gynecology. New York, Elsevier Health Sciences, 2004.
38.
Khalighi Sigarudi F, Jarvandi S, Taghizade M: Use of Medicinal Plants (in Persian). Tehran, Ketab Arjmand, 2011.
39.
Ehsani P, Nazayer H, Memari A: The effect of herbs (thyme, chamomile and sage) on bleeding in menstruation. J Women Cult 2014;5:127-140.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.